BIOMAT Database Logo BIOMAT Database Logo

Topically applied recombinant chemokine analogues fully protect macaques from vaginal simian-human immunodeficiency virus challenge. 2009

Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
Tulane National Primate Research Center, Covington, Louisiana, USA.

Effective strategies for preventing human immunodeficiency virus infection are urgently needed, but recent failures in key clinical trials of vaccines and microbicides highlight the need for new approaches validated in relevant animal models. Here, we show that 2 new chemokine (C-C motif) receptor 5 inhibitors, 5P12-RANTES (regulated on activation, normal T cell expressed and secreted) and 6P4-RANTES, fully protect against infection in the rhesus vaginal challenge model. These highly potent molecules, which are amenable to low-cost production, represent promising new additions to the microbicides pipeline.

UI MeSH Term Description Entries
D008251 Macaca A genus of the subfamily CERCOPITHECINAE, family CERCOPITHECIDAE, consisting of 16 species inhabiting forests of Africa, Asia, and the islands of Borneo, Philippines, and Celebes. Ape, Barbary,Ape, Black,Ape, Celebes,Barbary Ape,Black Ape,Celebes Ape,Macaque,Apes, Barbary,Apes, Black,Apes, Celebes,Barbary Apes,Black Apes,Celebes Apes,Macacas,Macaques
D011994 Recombinant Proteins Proteins prepared by recombinant DNA technology. Biosynthetic Protein,Biosynthetic Proteins,DNA Recombinant Proteins,Recombinant Protein,Proteins, Biosynthetic,Proteins, Recombinant DNA,DNA Proteins, Recombinant,Protein, Biosynthetic,Protein, Recombinant,Proteins, DNA Recombinant,Proteins, Recombinant,Recombinant DNA Proteins,Recombinant Proteins, DNA
D005260 Female Females
D000287 Administration, Topical The application of drug preparations to the surfaces of the body, especially the skin (ADMINISTRATION, CUTANEOUS) or mucous membranes. This method of treatment is used to avoid systemic side effects when high doses are required at a localized area or as an alternative systemic administration route, to avoid hepatic processing for example. Drug Administration, Topical,Administration, Topical Drug,Topical Administration,Topical Drug Administration,Administrations, Topical,Administrations, Topical Drug,Drug Administrations, Topical,Topical Administrations,Topical Drug Administrations
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D012367 RNA, Viral Ribonucleic acid that makes up the genetic material of viruses. Viral RNA
D014621 Vagina The genital canal in the female, extending from the UTERUS to the VULVA. (Stedman, 25th ed) Vaginas
D016097 Simian Acquired Immunodeficiency Syndrome Acquired defect of cellular immunity that occurs naturally in macaques infected with SRV serotypes, experimentally in monkeys inoculated with SRV or MASON-PFIZER MONKEY VIRUS; (MPMV), or in monkeys infected with SIMIAN IMMUNODEFICIENCY VIRUS. AIDS, Simian,SAIDS,Simian AIDS,Simian Acquired Immune Deficiency Syndrome,Simian Acquired Immuno-Deficiency Syndrome,AIDSs, Simian,Simian AIDSs,Simian Acquired Immuno Deficiency Syndrome
D018925 Chemokines Class of pro-inflammatory cytokines that have the ability to attract and activate leukocytes. They can be divided into at least three structural branches: C; (CHEMOKINES, C); CC; (CHEMOKINES, CC); and CXC; (CHEMOKINES, CXC); according to variations in a shared cysteine motif. Chemokine,Chemotactic Cytokine,Chemotactic Cytokines,Cytokines, Chemotactic,Intercrine,Intercrines,Cytokine, Chemotactic
D018946 Chemokine CCL5 A CC-type chemokine that is a chemoattractant for EOSINOPHILS; MONOCYTES; and LYMPHOCYTES. It is a potent and selective eosinophil chemotaxin that is stored in and released from PLATELETS and activated T-LYMPHOCYTES. Chemokine CCL5 is specific for CCR1 RECEPTORS; CCR3 RECEPTORS; and CCR5 RECEPTORS. The acronym RANTES refers to Regulated on Activation, Normal T Expressed and Secreted. CCL5 Chemokine,RANTES,RANTES Protein, T-Cell,CCL5, Chemokine,Chemokine, CCL5,RANTES Protein, T Cell,T-Cell RANTES Protein

Related Publications

Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
C5A Protects Macaques from Vaginal Simian-Human Immunodeficiency Virus Challenge.
January 2016, Antimicrobial agents and chemotherapy,
Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
Immune response of rhesus macaques to recombinant simian immunodeficiency virus gp130 does not protect from challenge infection.
January 1993, Journal of virology,
Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
Prior infection with a nonpathogenic chimeric simian-human immunodeficiency virus does not efficiently protect macaques against challenge with simian immunodeficiency virus.
July 1995, Journal of virology,
Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
Chemokine-adjuvanted electroporated DNA vaccine induces substantial protection from simian immunodeficiency virus vaginal challenge.
January 2016, Mucosal immunology,
Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
Rhesus macaques previously infected with simian/human immunodeficiency virus are protected from vaginal challenge with pathogenic SIVmac239.
March 1997, Journal of virology,
Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
Neutralizing antibody affords comparable protection against vaginal and rectal simian/human immunodeficiency virus challenge in macaques.
June 2016, AIDS (London, England),
Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
Multigene DNA priming-boosting vaccines protect macaques from acute CD4+-T-cell depletion after simian-human immunodeficiency virus SHIV89.6P mucosal challenge.
November 2003, Journal of virology,
Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
With minimal systemic T-cell expansion, CD8+ T Cells mediate protection of rhesus macaques immunized with attenuated simian-human immunodeficiency virus SHIV89.6 from vaginal challenge with simian immunodeficiency virus.
November 2008, Journal of virology,
Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
Evaluation of recombinant influenza virus-simian immunodeficiency virus vaccines in macaques.
August 2009, Journal of virology,
Ronald S Veazey, and Binhua Ling, and Linda C Green, and Erin P Ribka, and Jeffrey D Lifson, and Michael Piatak, and Michael M Lederman, and Donald Mosier, and Robin Offord, and Oliver Hartley
High beta-chemokine expression levels in lymphoid tissues of simian/human immunodeficiency virus 89.6-vaccinated rhesus macaques are associated with uncontrolled replication of simian immunodeficiency virus challenge inoculum.
June 2004, Journal of virology,
Copied contents to your clipboard!